Targeting Metabolic Remodeling in Triple Negative Breast Cancer in a Murine Model

Background: Chemotherapy is the backbone of systemic treatment for triple negative breast cancer (TNBC), which is one of the most relevant breast cancers molecular types due to the ability of tumor cells to develop drug resistance, highlighting the urgent need to design newer and safer drug combinat...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Castillo, Verónica, López-Urrutia, Eduardo, Villanueva-Sánchez, Octavio, Ávila-Rodríguez, Miguel Á., Zentella-Dehesa, Alejandro, Cortés-González, Carlo, López-Camarillo, César, Jacobo-Herrera, Nadia J, Pérez-Plasencia, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327367/
https://www.ncbi.nlm.nih.gov/pubmed/28243322
http://dx.doi.org/10.7150/jca.16387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327367/
https://www.ncbi.nlm.nih.gov/pubmed/28243322
http://dx.doi.org/10.7150/jca.16387

Ejemplares similares